Literature DB >> 30292939

A facile approach for development of a vaccine made of bacterial double-layered membrane vesicles (DMVs).

Sihan Wang1, Jin Gao1, Mo Li2, Liguo Wang2, Zhenjia Wang3.   

Abstract

Bacterial infections cause acute and chronic diseases. Antimicrobial resistance and aging-related immune weakness remain challenging in therapy of infectious diseases. Vaccines are however an alternative to prevent bacterial infections. Here we report a facile method to rapidly generate bacterium-membrane-formed nanovesicles as a vaccine using nitrogen cavitation. The vaccine is comprised of double-layered membrane vesicles (DMVs) characterized by cryo-TEM, biochemistry and proteomics, showing DMVs possess the integrity of bacterial membrane and contain a wide range of membrane proteins required for vaccination. In the mouse sepsis model induced by Pseudomonas aeruginosa, we found that DMVs can improve mouse survival after mice were immunized with DMVs. The increased adaptive immunity and unique biodistribution of DMVs were responsible for enhanced protection of bacterial infection. Our studies demonstrate that this simple and innovative approach using nitrogen cavitation would be a promising technology for vaccine developments.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  DMVs; Infections; Nanotechnology; OMVs; Pseudomonas aeruginosa; Vaccines

Mesh:

Substances:

Year:  2018        PMID: 30292939      PMCID: PMC6205512          DOI: 10.1016/j.biomaterials.2018.09.042

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  76 in total

Review 1.  Mechanisms of antibiotic resistance in Pseudomonas aeruginosa.

Authors:  P A Lambert
Journal:  J R Soc Med       Date:  2002       Impact factor: 5.344

2.  An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow.

Authors:  M B Lutz; N Kukutsch; A L Ogilvie; S Rössner; F Koch; N Romani; G Schuler
Journal:  J Immunol Methods       Date:  1999-02-01       Impact factor: 2.303

3.  Purification of outer membrane vesicles from Pseudomonas aeruginosa and their activation of an IL-8 response.

Authors:  Susanne J Bauman; Meta J Kuehn
Journal:  Microbes Infect       Date:  2006-06-05       Impact factor: 2.700

Review 4.  Advances and Opportunities in Nanoparticle- and Nanomaterial-Based Vaccines against Bacterial Infections.

Authors:  Leon Chien-Wei Lin; Saborni Chattopadhyay; Jung-Chen Lin; Che-Ming Jack Hu
Journal:  Adv Healthc Mater       Date:  2018-03-06       Impact factor: 9.933

Review 5.  Lipopolysaccharide: a tool and target in enterobacterial vaccine development.

Authors:  Gábor Nagy; Tibor Pál
Journal:  Biol Chem       Date:  2008-05       Impact factor: 3.915

6.  DNA-containing membrane vesicles of Pseudomonas aeruginosa PAO1 and their genetic transformation potential.

Authors:  Marika Renelli; Valério Matias; Reggie Y Lo; Terry J Beveridge
Journal:  Microbiology (Reading)       Date:  2004-07       Impact factor: 2.777

Review 7.  New concepts of the pathogenesis of cystic fibrosis lung disease.

Authors:  R C Boucher
Journal:  Eur Respir J       Date:  2004-01       Impact factor: 16.671

Review 8.  Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies.

Authors:  Samir Mitragotri; Paul A Burke; Robert Langer
Journal:  Nat Rev Drug Discov       Date:  2014-08-08       Impact factor: 84.694

9.  Immunization with Escherichia coli outer membrane vesicles protects bacteria-induced lethality via Th1 and Th17 cell responses.

Authors:  Oh Youn Kim; Bok Sil Hong; Kyong-Su Park; Yae Jin Yoon; Seng Jin Choi; Won Hee Lee; Tae-Young Roh; Jan Lötvall; Yoon-Keun Kim; Yong Song Gho
Journal:  J Immunol       Date:  2013-03-20       Impact factor: 5.422

10.  Neisseria lactamica protects against experimental meningococcal infection.

Authors:  Kerry J Oliver; Karen M Reddin; Philippa Bracegirdle; Michael J Hudson; Ray Borrow; Ian M Feavers; Andrew Robinson; Keith Cartwright; Andrew R Gorringe
Journal:  Infect Immun       Date:  2002-07       Impact factor: 3.441

View more
  12 in total

1.  pH-Responsive Nanoparticles Targeted to Lungs for Improved Therapy of Acute Lung Inflammation/Injury.

Authors:  Can Yang Zhang; Wenjing Lin; Jin Gao; Xutong Shi; Maryam Davaritouchaee; Amy E Nielsen; Rock J Mancini; Zhenjia Wang
Journal:  ACS Appl Mater Interfaces       Date:  2019-04-24       Impact factor: 9.229

2.  Generation of Membrane-Derived Nanovesicles by Nitrogen Cavitation for Drug Targeting Delivery and Immunization.

Authors:  Jin Gao; Mindy Lee; Xinyue Dong; Zhenjia Wang
Journal:  Methods Mol Biol       Date:  2022

Review 3.  Recent advances in photodynamic therapy for cancer and infectious diseases.

Authors:  Xutong Shi; Can Yang Zhang; Jin Gao; Zhenjia Wang
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2019-05-06

Review 4.  Generation, purification and engineering of extracellular vesicles and their biomedical applications.

Authors:  Jin Gao; Xinyue Dong; Zhenjia Wang
Journal:  Methods       Date:  2019-11-30       Impact factor: 3.608

5.  Bacterial extracellular vesicle-coated multi-antigenic nanovaccines protect against drug-resistant Staphylococcus aureus infection by modulating antigen processing and presentation pathways.

Authors:  Gang Chen; Yanan Bai; Zhenzhen Li; Fei Wang; Xuelian Fan; Xin Zhou
Journal:  Theranostics       Date:  2020-05-30       Impact factor: 11.556

6.  RGD-expressed bacterial membrane-derived nanovesicles enhance cancer therapy via multiple tumorous targeting.

Authors:  Jin Gao; Sihan Wang; Xinyue Dong; Zhenjia Wang
Journal:  Theranostics       Date:  2021-01-15       Impact factor: 11.556

7.  Human neutrophil membrane-derived nanovesicles as a drug delivery platform for improved therapy of infectious diseases.

Authors:  Jin Gao; Xinyue Dong; Yujie Su; Zhenjia Wang
Journal:  Acta Biomater       Date:  2021-01-18       Impact factor: 8.947

8.  Recent advances in cell membrane-camouflaged nanoparticles for inflammation therapy.

Authors:  Rongtao Zhang; Siqiong Wu; Qian Ding; Qingze Fan; Yan Dai; Shiwei Guo; Yun Ye; Chunhong Li; Meiling Zhou
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

9.  Recombinant Pseudomonas Bionanoparticles Induce Protection against Pneumonic Pseudomonas aeruginosa Infection.

Authors:  Peng Li; Xiuran Wang; Xiangwan Sun; Jesse Cimino; Ziqiang Guan; Wei Sun
Journal:  Infect Immun       Date:  2021-07-26       Impact factor: 3.609

Review 10.  Recent Advances of Nanotechnology-Facilitated Bacteria-Based Drug and Gene Delivery Systems for Cancer Treatment.

Authors:  Chaojie Zhu; Zhiheng Ji; Junkai Ma; Zhijie Ding; Jie Shen; Qiwen Wang
Journal:  Pharmaceutics       Date:  2021-06-24       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.